MetaModix

About:

MetaModix manufactures surgical and medical instruments for the treatment of metabolic disease and Type II diabetes.

Top Investors: Antipodean Advisors

Description:

MetaModix manufactures surgical and medical instruments for the treatment of metabolic diseases and Type II diabetes. The company's first product, the EndoSleeve, is designed to be a safer and more cost-effective treatment option for patients suffering from type 2 diabetes, NASH, and obesity. It was founded in 2009 and is headquartered in Plymouth, Minnesota, United States.

Total Funding Amount:

$5.71M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Plymouth, Minnesota, United States

Founded Date:

2009-01-01

Contact Email:

kedar(AT)metamodix.com

Founders:

Kedar R. Belhe

Number of Employees:

1-10

Last Funding Date:

2023-01-26

IPO Status:

Private

Industries: